Terms: = Lymphoma AND NT5C2, ENSG00000076685, 22978, P49902, PNT5, NT5B, GMP, cN-II AND Prognosis
7 results:
1. Activation of STING by SAMHD1 Deficiency Promotes PANoptosis and Enhances Efficacy of PD-L1 Blockade in Diffuse Large B-cell lymphoma.
Cai Y; Chen X; Lu T; Fang X; Ding M; Yu Z; Hu S; Liu J; Zhou X; Wang X
Int J Biol Sci; 2023; 19(14):4627-4643. PubMed ID: 37781035
[TBL] [Abstract] [Full Text] [Related]
2. Pediatric ALL relapses after allo-SCT show high individuality, clonal dynamics, selective pressure, and druggable targets.
Hoell JI; Ginzel S; Kuhlen M; Kloetgen A; Gombert M; Fischer U; Hein D; Demir S; Stanulla M; Schrappe M; Zur Stadt U; Bader P; Babor F; Schuster F; Strahm B; Alten J; Moericke A; Escherich G; von Stackelberg A; Thiele R; McHardy AC; Peters C; Bornhauser B; Bourquin JP; Krause S; Enczmann J; Meyer LH; Eckert C; Borkhardt A; Meisel R
Blood Adv; 2019 Oct; 3(20):3143-3156. PubMed ID: 31648313
[TBL] [Abstract] [Full Text] [Related]
3. Clonal evolution mechanisms in nt5c2 mutant-relapsed acute lymphoblastic leukaemia.
Tzoneva G; Dieck CL; Oshima K; Ambesi-Impiombato A; Sánchez-Martín M; Madubata CJ; Khiabanian H; Yu J; Waanders E; Iacobucci I; Sulis ML; Kato M; Koh K; Paganin M; Basso G; Gastier-Foster JM; Loh ML; Kirschner-Schwabe R; Mullighan CG; Rabadan R; Ferrando AA
Nature; 2018 Jan; 553(7689):511-514. PubMed ID: 29342136
[TBL] [Abstract] [Full Text] [Related]
4. [PRPS1 Expression in Children with Acute Leukemia and Its Clinical Significance].
Ma YM; An XZ; Guan XM; Kong QL; Li PF; Xian Y; Xiao JW; Meng Y; Liang SY; Yu J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):311-317. PubMed ID: 28446267
[TBL] [Abstract] [Full Text] [Related]
5. [nt5c2 expression in children with acute leukemia and its clinical significance].
Wang Y; An X; Liu J; Zhang N; Liu Z; Liang S; Yu J
Zhonghua Xue Ye Xue Za Zhi; 2015 Sep; 36(9):748-53. PubMed ID: 26462774
[TBL] [Abstract] [Full Text] [Related]
6. Relapse-specific mutations in nt5c2 in childhood acute lymphoblastic leukemia.
Meyer JA; Wang J; Hogan LE; Yang JJ; Dandekar S; Patel JP; Tang Z; Zumbo P; Li S; Zavadil J; Levine RL; Cardozo T; Hunger SP; Raetz EA; Evans WE; Morrison DJ; Mason CE; Carroll WL
Nat Genet; 2013 Mar; 45(3):290-4. PubMed ID: 23377183
[TBL] [Abstract] [Full Text] [Related]
7. BCR-ABL1 kinase-dependent alteration of mRNA metabolism: potential alternatives for therapeutic intervention.
Perrotti D; Harb JG
Leuk Lymphoma; 2011 Feb; 52 Suppl 1(Suppl 1):30-44. PubMed ID: 21299458
[TBL] [Abstract] [Full Text] [Related]
